These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7527944)

  • 1. Effects of divided doses of steroids on side effects, cytokines, and activation of complement and granulocytes, coagulation and fibrinolysis after OKT3.
    Bemelman FJ; Buysmann S; Wilmink JM; Surachno S; Hack CE; Schellekens PT; ten Berge RJ
    Transplant Proc; 1994 Dec; 26(6):3096-7. PubMed ID: 7527944
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of coagulation and fibrinolysis during treatment with OKT3.
    ten Berge RJ; Raasveld MH; van Diepen FN; Hack CE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):566-7. PubMed ID: 8438416
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome.
    Suharti C; van Gorp EC; Setiati TE; Dolmans WM; Djokomoeljanto RJ; Hack CE; ten CH; van der Meer JW
    Thromb Haemost; 2002 Jan; 87(1):42-6. PubMed ID: 11858187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of coagulation and fibrinolysis following OKT3 administration to renal transplant recipients: association with distinct mediators.
    Raasveld MH; Hack CE; ten Berge IJ
    Thromb Haemost; 1992 Sep; 68(3):264-7. PubMed ID: 1279831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of intravascular coagulation and fibrinolysis in cases of APL].
    Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Byori; 1989 Apr; Spec No 81():224-8. PubMed ID: 2526885
    [No Abstract]   [Full Text] [Related]  

  • 6. Consequences of OKT3 administration via continuous infusion as compared to bolus infusion.
    ten Berge RJ; Buysmann S; van Diepen FN; Surachno S; Hack CE
    Transplant Proc; 1996 Dec; 28(6):3217-20. PubMed ID: 8962246
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
    García Frade LJ; García Avello A
    Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
    Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
    Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
    Madoiwa S
    Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
    Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
    Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
    [No Abstract]   [Full Text] [Related]  

  • 11. Diphasic increase in thrombin-antithrombin III complex in blood from the internal jugular vein following severe head injury.
    Suzuki M; Motohashi O; Nishino A; Shiina V; Mizoi K; Yoshimoto T; Kameyama M; Onuma T
    Thromb Haemost; 1994 Jan; 71(1):155-7. PubMed ID: 8165638
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
    Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of intravascular coagulation in Bell's palsy.
    Omori H; Ikeda M; Kukimoto N; Kawamoto H; Ikui A; Tomita H
    Eur Arch Otorhinolaryngol; 1994 Dec; ():S471-2. PubMed ID: 10774425
    [No Abstract]   [Full Text] [Related]  

  • 14. Pentoxifylline reduces the first-dose reactions following OKT3.
    Vincenti FG; Vasconcelos M; Birnbaum JL; Tomlanovich SJ; Amend WJ; Melzer JS; Snyder JP
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):57-9. PubMed ID: 8465428
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of steroid resistant rejection following renal transplantation: benefits and risks of OKT3 therapy.
    Kehinde EO; Feehally J; Scriven SD; Veitch PS; Bell PR
    Transplant Proc; 1996 Jun; 28(3):1449-50. PubMed ID: 8658735
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of proteinase/antiproteinase inhibitor disequilibrium in the bioincompatibility induced by artificial surfaces.
    Deppisch R; Haug U; Göhl H; Ritz E
    Nephrol Dial Transplant; 1994; 9 Suppl 3():17-23. PubMed ID: 7521027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
    Kanamori N; Koiwa F; Uda S
    Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autotransfusion in coronary artery bypass grafting: disparity in laboratory tests and clinical performance.
    Flom-Halvorsen HI; Ovrum E; Tangen G; Brosstad F; Ringdal MA; Oystese R
    J Thorac Cardiovasc Surg; 1999 Oct; 118(4):610-7. PubMed ID: 10504624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients.
    Roayaie S; Sheiner PA; Emre S; Guy S; Schwartz ME; Boros P; Miller CM
    Mediators Inflamm; 2000; 9(3-4):141-6. PubMed ID: 11132770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.